Rheumatic Fever: time series study

Authors

DOI:

https://doi.org/10.5281/zenodo.13627549

Keywords:

Regional Inequalities, Health Disparities, Rheumatic Fever, Hospitalizations

Abstract

Rheumatic fever is an autoimmune inflammatory disease that occurs as a complication of streptococcal infections, being particularly prevalent in regions with unfavorable socioeconomic conditions, where it mainly affects the heart, joints, and nervous system. This study analyzes hospitalizations due to acute rheumatic fever in Brazil between January 2010 and June 2024, using data from the Hospital Information System of the Unified Health System (SIH/SUS), with a focus on regional disparities and their possible causes. The Northeast Region leads in the number of hospitalizations, with 38.11% of the cases, reflecting the influence of factors such as high population density in urban areas with deficient healthcare infrastructure and socioeconomic conditions that favor the spread of streptococcal infections, the main triggers of rheumatic fever. The Southeast Region, the second most affected, accounts for 29.67% of hospitalizations, where the combination of high population density and internal inequalities contributes to the disease's spread. The North, South, and Midwest regions show lower incidences, possibly reflecting better living conditions and access to healthcare, especially in the South and Midwest. Gender analysis reveals a slight female predominance (51.36%), suggesting the influence of biological and hormonal factors on susceptibility to chronic complications. The concentration of cases in middle-aged adults highlights the persistence of rheumatic fever throughout life, with a more significant impact on the 50 to 59 and 40 to 49 age groups. These findings emphasize the need for regionally and demographically adapted public health policies, with an emphasis on prevention, early detection, and appropriate treatment, especially in the most affected areas.

References

AUALA, T. et al. Acute rheumatic fever and rheumatic heart disease: highlighting the role of group A Streptococcus in the global burden of cardiovascular disease. Pathogens, v. 11, n. 5, p. 496, 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145486/. Acesso em 24 jul. 2024.

DIXIT, J. et al. Health related quality of life among rheumatic fever and rheumatic heart disease patients in India. PLoS One, v. 16, n. 10, p. e0259340, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34714892/. Acesso em 02 ago. 2024.

EMRE, I. E. et al. The analysis of the effects of acute rheumatic fever in childhood on cardiac disease with data mining. International journal of medical informatics, v. 123, p. 68-75, 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30654905/. Acesso em 27 jul. 2024.

FIGUEIREDO, E. T. et al. Rheumatic fever: a disease without color. Arquivos Brasileiros de Cardiologia, v. 113, n. 3, p. 345-354, 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31365604/. Acesso em 27 jul. 2024.

JAIMES-REYES, M. A. et al. Current situation of acute rheumatic fever and rheumatic heart disease in Latin America and the Caribbean: a systematic review. Global Heart, v. 17, n. 1, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36199563/. Acesso em 28 jul. 2024.

JUNCKER, A. S.; APPENZELLER, S.; DE SOUZA, J. M. Central Nervous System Involvement in Systemic Autoimmune Rheumatic Diseases—Diagnosis and Treatment. Pharmaceuticals, v. 17, n. 8, p. 1044, 2024. Disponível em: https://www.mdpi.com/1424-8247/17/8/1044. Acesso em 24 jul. 2024.

LIANG, Y. et al. The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review. Frontiers in Cardiovascular Medicine, v. 10, p. 1183606, 2023. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242100/. Acesso em 24 jul. 2024.

LONGENECKER, C. T. Rheumatic fever in Brazil: What color should it be?. Arquivos Brasileiros de Cardiologia, v. 113, n. 3, p. 355-356, 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31621774/. Acesso em 03 ago. 2024.

MARAFON, J. C. et al. INTERNAÇÃO POR FEBRE REUMÁTICA ENTRE 5 E 14 ANOS, NA ÚLTIMA DÉCADA NO BRASIL. Revista Uningá, v. 57, n. S1, p. 043-044, 2020. Disponível em: https://revista.uninga.br/uninga/article/view/3883#:~:text=Por%20meio%20da%20an%C3%A1lise%2C%20foi,um%20valor%20significativo%20de%20casos. Acesso em 29 jul. 2024.

MIRANDA, B. A. et al. Doença reumática do coração no Brasil: dez anos de análise epidemiológica na população infantil. In: Congresso Médico Acadêmico UniFOA. 2019. Disponível em: https://conferenciasunifoa.emnuvens.com.br/congresso-medvr/article/view/245. Acesso em 28 jul. 2024.

ORTONA, E.; PIERDOMINICI, M.; RIDER, V. Editorial: sex hormones and gender differences in immune responses. Front Immunol, v. 10, p. 1076. 2019. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530401/. Acesso em 05 ago. 2024.

RALPH, A. P. et al. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Medical Journal of Australia, v. 214, n. 5, p. 220-227, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33190309/. Acesso em 02 ago. 2024.

RWEBEMBERA, J. et al. Recent advances in the rheumatic fever and rheumatic heart disease continuum. Pathogens, v. 11, n. 2, p. 179, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35215123/. Acesso em 03 ago. 2024.

ZÜHLKE, L. et al. Clinical outcomes in 3343 children and adults with rheumatic heart disease from 14 low-and middle-income countries: two-year follow-up of the Global Rheumatic Heart Disease Registry (the REMEDY Study). Circulation, v. 134, n. 19, p. 1456-1466, 2016. Disponível em: https://pubmed.ncbi.nlm.nih.gov/27702773/. Acesso em 05 ago. 2024.

Published

2024-09-02

Issue

Section

Articles

How to Cite

TAYT-SOHN, Bárbara dos Santos et al. Rheumatic Fever: time series study. Journal of Social Issues and Health Sciences (JSIHS), [S. l.], v. 1, n. 6, 2024. DOI: 10.5281/zenodo.13627549. Disponível em: https://ojs.thesiseditora.com.br/index.php/jsihs/article/view/161.. Acesso em: 7 dec. 2025.